A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa. (Q38730996)

5 September 2017

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

main subject

Ebola vaccine

0 references

Orthoebolavirus zairense

0 references

author

Angela Huttner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Mariëlle C Haks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Laurent Kaiser

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Donata Medaglini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Peter Gottfried Kremsner

16

object named as

Peter G Kremsner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Selidji Todagbe Agnandji

7

object named as

Selidji Todagbe Agnandji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

17

Tom H M Ottenhoff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

author name string

Christophe Combescure

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Stéphane Grillet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Edwin Quinten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Christine Modoux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Jessica Brosnahan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Julie-Anne Dayer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Ali M Harandi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Tom Monath

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

VEBCON and VSV-EBOVAC Consortia

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Pascale Roux-Lombard

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

Claire-Anne Siegrist

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

1 April 2017

1 reference

Science Translational Medicine

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

issue

385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

Ebola vaccine--an urgent international priority

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Vesicular stomatitis virus: re-inventing the bullet

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Oncolytic viruses: From bench to bedside with a focus on safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Ebola vaccine R&D: Filling the knowledge gaps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

The Role of Cytokines and Chemokines in Filovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Shed GP of Ebola virus triggers immune activation and increased vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Human asymptomatic Ebola infection and strong inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Ebola virus exploits a monocyte differentiation program to promote its entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Acute reactogenicity after intramuscular immunization with recombinant vesicular stomatitis virus is linked to production of IL-1β

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Cytokine and chemokine responses to Japanese encephalitis live attenuated vaccine in a human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Focused human gene expression profiling using dual-color reverse transcriptase multiplex ligation-dependent probe amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, Northeastern Gabon, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Monocyte chemoattractant protein-1 (MCP-1): an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Biological properties of extracellular vesicles and their physiological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Pathways for cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Innate immune recognition of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Involvement of interferon in virus-induced lymphopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Collagen-induced arthritis is exacerbated in IL-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Human infection with the virus of vesicular stomatitis during an epizootic

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1701

TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28404856

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28404856

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCITRANSLMED.AAJ1701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6379059&resulttype=core&format=json

13 May 2020

1 reference